All Press Releases

Axial Biotherapeutics nets $25M for clinical gut-brain axis studies into autism and Parkinson’s February 28, 2019

Torque and Thermo Fisher Scientific Announce Collaboration to Build State-of-the-Art Facility to Manufacture Torque’s Deep-Primed T Cell Immunotherapies February 13, 2019

Affinivax, Inc. announces initiation of Phase 1/2 clinical study of ASP3772, its novel pneumococcal MAPS vaccine, in collaboration with Astellas February 13, 2019

Obsidian Therapeutics Announces Strategic Collaboration with Celgene to Develop Novel Cell Therapies with Tunable Immunomodulatory Factors, Opening Potential for CAR-T and Other Cellular Medicines in New Settings January 18, 2019

Apic Bio Announces $40M Series A Financing to Advance Novel Gene Therapies for Rare Genetic Disorders January 7, 2019

The 2019 30-under-30 getting personal to fix the system January 4, 2019

Astellas Pharma : buys Potenza Therapeutics for up to $405m December 21, 2018

Rheostat Therapeutics Announces $23 Million Series A Financing; To Develop Potential Treatments for Neurodegenerative Diseases November 26, 2018

QurAlis Raises $5.5 Million Seed Round - Wins Pfizer Sponsored Golden Ticket to LabCentral November 19, 2018

Biotech ALS-focused QurAlis raises $5.5M in seed money, wins Pfizer ticket to LabCentral November 19, 2018

1 ... 5 6 7 ... 21